Perampanel as First Adjunctive Treatment in Patients with Focal-Onset Seizures in the FAME Study: Post hoc Analyses of Dose-Related Efficacy, Safety and Clinical Factors Associated with Response.
J Epilepsy Res
; 12(1): 6-12, 2022 Jun.
Article
en En
| MEDLINE
| ID: mdl-35910330
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
J Epilepsy Res
Año:
2022
Tipo del documento:
Article